ConductScience.org, home

Paper32199764

The Myelodepletive Phenotype in Myelofibrosis: Clinical Relevance and Therapeutic Implication.

Marcellino BK and 2 others. Clin Lymphoma Myeloma Leuk, 2020. Cited by 48 papers, by iCite.

Cite this record

ConductScience Library. The Myelodepletive Phenotype in Myelofibrosis: Clinical Relevance and Therapeutic Implication. Papers, record 32199764. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32199764

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Myelodepletive Phenotype in Myelofibrosis: Clinical Relevance and Therapeutic Implication.
PubMed
Journal
Clin Lymphoma Myeloma Leuk
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
2.44
iCite
Revised in PubMed
2021-08-25
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marcellino BKBridget K
2Verstovsek SSrdan
3Mascarenhas JJohn

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Primary MyelofibrosisMajor topic
Humans
Phenotype

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
41400273The hematopoietic stem cells supportive megakaryocytes as shapers of the bone marrow niche.Eur J Histochem2025https://conductscience.org/library/papers/41400273PubMed
41030319The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor Therapies.Blood Lymphat Cancer2025https://conductscience.org/library/papers/41030319PubMed
40643151Thrombocytopenia in myelofibrosis is characterized by inflammatory megakaryocytes with reduced G6B expression.Blood2025https://conductscience.org/library/papers/40643151PubMed
40454401A novel application of XPO1 inhibition for the treatment of myelofibrosis.Blood Neoplasia2024https://conductscience.org/library/papers/40454401PubMed
40361317Extreme Thrombocytosis in Patients with Overt Myelofibrosis and Its Clinical Associations.Cancers (Basel)2025https://conductscience.org/library/papers/40361317PubMed
39897086Cytopenic overt primary myelofibrosis at presentation: Analysis of outcomes in the prospective, real-world ERNEST-2 registry.Hemasphere2025https://conductscience.org/library/papers/39897086PubMed
39400386Pacritinib Response Is Associated With Overall Survival in Myelofibrosis: PERSIST-2 Landmark Analysis of Survival.Eur J Haematol2025https://conductscience.org/library/papers/39400386PubMed
39114304Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives.Front Oncol2024https://conductscience.org/library/papers/39114304PubMed
39062946The Variation in the Traits Ameliorated by Inhibitors of JAK1/2, TGF-β, P-Selectin, and CXCR1/CXCR2 in the Gata1low Model Suggests That Myelofibrosis Should Be Treated by These Drugs in Combination.Int J Mol Sci2024https://conductscience.org/library/papers/39062946PubMed
38672793Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis.Life (Basel)2024https://conductscience.org/library/papers/38672793PubMed
38612873Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease Progression.Int J Mol Sci2024https://conductscience.org/library/papers/38612873PubMed
37894394A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis.Cancers (Basel)2023https://conductscience.org/library/papers/37894394PubMed
37835392Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study.Cancers (Basel)2023https://conductscience.org/library/papers/37835392PubMed
37747591Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group.Clin Exp Med2023https://conductscience.org/library/papers/37747591PubMed
37444441Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments.Cancers (Basel)2023https://conductscience.org/library/papers/37444441PubMed
37439808A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis.Clin Cancer Res2023https://conductscience.org/library/papers/37439808PubMed
37243913The role of therapy in the outcome of patients with myelofibrosis.Cancer2023https://conductscience.org/library/papers/37243913PubMed
36891574Novel therapeutics for myelofibrosis.Blood Res2023https://conductscience.org/library/papers/36891574PubMed
36797153SOHO State of the Art Updates and Next Questions: Novel Therapeutic Strategies in Development for Myelofibrosis.Clin Lymphoma Myeloma Leuk2023https://conductscience.org/library/papers/36797153PubMed
36485113New approaches to tackle cytopenic myelofibrosis.Hematology Am Soc Hematol Educ Program2022https://conductscience.org/library/papers/36485113PubMed

See all 34 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
BCR613PubTator's text mininghttps://conductscience.org/library/genes/613NCBI Gene
CALR811PubTator's text mininghttps://conductscience.org/library/genes/811NCBI Gene
JAK23717PubTator's text mininghttps://conductscience.org/library/genes/3717NCBI Gene
MPL4352PubTator's text mininghttps://conductscience.org/library/genes/4352NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32199764

GET https://conductscience.org/api/papers/v1/32199764/cited_by?page=2